Related Federal Cases
- Bausch and Lannett Hit with $17.85M Fine for Generic Drug Price Fixing · New York
- OneMain Financial Squeezes NYers in Debt Trap: AG James Sues · New York
- James Warns Homeowners: Snowplow Scams & Price Gouging Loom · New York
- NY AG James Cracks Down on Storm Price Gouging · New York
- AG James Slams Price Gouging as NY Storm Approaches · New York
Apotex Price-Fixing: NYers Can Claim Millions in Restitution
NEW YORK – A scheme to bleed everyday New Yorkers dry is finally facing consequences. New York Attorney General Letitia James, alongside a coalition of 49 other Attorneys General, is pushing for victims to claim their share of a $39.1 million settlement with generic drug manufacturer Apotex Corp. for its role in a massive, years-long conspiracy to inflate the prices of essential medications and stifle competition. This isn’t just about dollars and cents; it’s about companies prioritizing profit over the health and well-being of those who need life-saving drugs.
The investigation revealed a calculated effort to jack up prices – in some cases by a staggering 1,000 percent – on crucial medications treating conditions ranging from diabetes and heart disease to cancer and ADHD. This isn’t a case of market fluctuation; it’s a deliberate, illegal manipulation of the system. Attorney General James stated, “When companies collude behind closed doors to raise prescription drug prices, they put everyday New Yorkers at serious risk…I urge any New Yorker who may have been a victim of this scheme to check their eligibility and claim the restitution they are owed.”
If you purchased a generic prescription drug listed here between May 2009 and December 2019, you may be entitled to compensation. The path to claiming your share is straightforward: call 1-866-290-0182 (toll-free), email info@AGGenericDrugs.com, or visit www.AGGenericDrugs.com. Don’t leave money on the table – this is a chance to fight back against corporate greed.
This settlement with Apotex builds on a previous $10 million agreement with Heritage Pharmaceuticals and is part of a larger, ongoing investigation targeting multiple pharmaceutical companies for price fixing. The Attorney General’s Office (OAG) has filed three lawsuits. The first complaint named Heritage and 17 other corporate defendants, along with two individuals and 15 generic drugs. Former Heritage executives Jeffery Glazer and Jason Malek have already entered into settlement agreements and are cooperating with investigators. A second complaint targeted Teva Pharmaceuticals and 19 other major generic manufacturers, naming 16 senior executives. The third, focusing on 80 topical generic drugs, involves 26 corporate defendants and 10 individuals.
The lawsuits allege a widespread, coordinated conspiracy to fix prices, eliminate competition, and rig bids for over 100 different generic drugs. The evidence paints a disturbing picture of industry executives meeting at lavish dinners, “girls’ nights out,” and golf outings, communicating through a constant stream of calls, emails, and texts to plan their illegal activities. They used coded language like “fair share,” “playing nice in the sandbox,” and “responsible competitor” to mask their collusion, essentially creating a cartel to maximize profits at the expense of patients.
The drugs affected by this scheme cover a wide range – tablets, capsules, creams, and ointments – and treat a diverse spectrum of conditions, including antibiotics, antidepressants, contraceptives, and anti-inflammatory medications. This wasn’t a targeted attack on a single drug; it was a systemic effort to exploit the healthcare system and line the pockets of those at the top. The OAG and its fellow Attorneys General are determined to hold these companies accountable and ensure that New Yorkers have access to affordable, life-saving medications.
Key Facts
- State: New York
- Agency: NY AG
- Category: Fraud & Financial Crimes
- Source: Official Source ↗
🔒 Get the grimiest stories delivered weekly. Subscribe free →
Browse More
MORE FEDERAL CRIME NEWS
US NewsUS NewsUS NewsUS News